Steve Bates BIA: Antimicrobial Resistance (AMR)- A Global Issue




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Steve Bates BIA: Antimicrobial Resistance (AMR)- A Global Issue
Released on: September 17, 2015. © PharmaVentures Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Dame Sally Davies, The Chief Medical Officer for England highlighted the problem of antimicrobial resistance in her 2013 annual report and this subsequently led to the UK cross-government five-year (2013-2018) antimicrobial resistance strategy.
  • Summary
  • Transcript
  • Company
Dame Sally Davies, The Chief Medical Officer for England highlighted the problem of antimicrobial resistance in her 2013 annual report and this subsequently led to the UK cross-government five-year (2013-2018) antimicrobial resistance strategy.During BIO 2015, Fintan Walton, CEO of PharmaVentures caught up with Steve Bates of the BIA to see how the UK Five Year Plan is progressing.
Dame Sally Davies, The Chief Medical Officer for England highlighted the problem of antimicrobial resistance in her 2013 annual report and this subsequently led to the UK cross-government five-year (2013-2018) antimicrobial resistance strategy.During BIO 2015, Fintan Walton, CEO of PharmaVentures caught up with Steve Bates of the BIA to see how the UK Five Year Plan is progressing.
BioIndustry Association (BIA)